Clinical Trial Update: Everolimus for Treating Pediatric Patients With Recurrent or Refractory Tumors [Phase 1]

View source ↗

Summary

A phase 1 trial evaluating everolimus in pediatric patients with recurrent or refractory tumors, including brain tumors, rhabdomyosarcoma, and soft tissue sarco…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Tumor
• Rhabdomyosarcoma
• Soft Tissue Sarcoma

Drugs mentioned

• Afinitor (everolimus)

Snippet

Sponsor: St. Jude Children's Research Hospital | Conditions: Tumors, Brain Tumors | Phase 1 | Status: COMPLETED